Navigation Links
Medimmune announces phase 2 safety data for anti-RSV antibody and national RSV surveillance results
Date:10/4/2007

SAN DIEGO, October 4, 2007 MedImmune, Inc. today announced results from two important studies presented at the 2007 Infectious Diseases Society of America (IDSA) 45th Annual Meeting adding to the body of knowledge about respiratory syncytial virus (RSV). RSV is a viral pathogen that produces annual outbreaks usually between fall and spring. While RSV typically manifests cold-like symptoms in healthy children, it can prove to be a very serious respiratory illness for premature infants and is the leading cause of respiratory infections for newborns each year. MedImmune has long been committed to developing and improving products for prevention of RSV disease and to enhancing the body of knowledge about RSV epidemiology.

MedImmune continues to forge ahead with its aggressive strategy to help combat RSV disease, said Edward M. Connor, M.D., executive vice president and chief medical officer. We are pleased to present new Phase 2 data at IDSA regarding motavizumab, a key investigational monoclonal antibody (MAb) within our product development portfolio that we are currently preparing for regulatory submission in the United States.

Connor added, We will also present data regarding RSV surveillance at IDSA. These data show regional variability of RSV in the community, particularly in the southernmost United States. We believe that a better understanding of the regional variation in the timing of RSV may help inform decisions about timing of RSV prophylaxis for children at risk for serious RSV disease.

Data pertaining to MedImmunes anti-RSV initiatives that will be presented during the IDSA meeting include:

  • Safety, Tolerability, and Immunogenicity of Motavizumab in Young Children After a Second Season of RSV Prophylaxis (Poster Presentation #233) Katia G. Abarca, M.D., Infectious Diseases and Molecular Virology Laboratory, Universidad Catlica de Chile, Friday, October 5, 2007; 12:30 2:00 p.m. in Poster Halls G-H
    '/>"/>


Contact: Tor Constantino
constantinos@medimmune.com
301-398-5801
Edelman Public Relations
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)...ralization ready at Passport .../ -- New vaccine requirements will affect,anyone w...o the U.S. and,anyone seeking adjustment of status...of of vaccinations against vaccine-preventable dis...ee on Immunization Practices.,Passport Health, a c...
(Date:7/23/2008)...rm count, motility, study finds , , THUR...lly invasive procedure can treat a common cause of...f having a baby, a new study finds. , The condi...lood vessels in the scrotum which prevents the nor...testicles. A minimally invasive radiological proce...
(Date:7/23/2008)...may be tough, but,Hollywood,s young stars like Lan...ing new smile to boost confidence. Cosmetic dentis...nts beam in on success, citing his,experience that...nce they,need for stardom. In agreement is Landon ...e designed by Dr. Kosdon., MTV,s Rock The Cradle ...
(Date:7/23/2008)...rouble, the worse their performance , , ...en suffering from coronary heart disease seem to f...And the longer the person had had heart disease, t...as reasoning, vocabulary and verbal fluency, accor...ean Heart Journal . , The research, however, ha...
Breaking Medicine News(10 mins):Health News:USCIS Tightens Vaccination Requirements 2Health News:Simple Procedure Improves Male Fertility 2Health News:Simple Procedure Improves Male Fertility 3Health News:Rock The Cradle's Bad Boy Landon Brown Owes His Irresistible New Smile to Dr. Michael Kosdon 2Health News:Coronary Disease Dulls Cognitive Skills 2
...a Corporation announced that, in conjunction with ...T), both parties have agreed for reasons of futil...) for the treatment of cystic fibrosis (CF). Genae...amine in prostate cancer, which is an investigator...
...li, daughter of Bangladeshi immigrants to the Unit...2007. Nora, 17, won the final competition, held i... than $60,000, The Daily Star said Wednesday, quot..."I just want to start a business and maybe even st...
...owth of Internet applications in healthcare has be...g increasingly involved in the healthcare service...acteristics that distinguish them from traditional...r in driving the use of the Internet in healthcare...
...en in Somerville town in Massachusetts are losing ... take notice. The kids of Somerville, a town of ...nutrition programme aimed at helping them learn he...hem throughout their lives. As a result the Somerv...
Other Medicine News:Health News:Genaera Discontinues Lomucin in Cystic Fibrosis Studies 2Health News:Benefits From the Use of the Internet in Healthcare Applications Highlighted 2Health News:Benefits From the Use of the Internet in Healthcare Applications Highlighted 3Health News:Somerville, A Town Committed to Tackle Obesity Among Kids 2Health News:Somerville, A Town Committed to Tackle Obesity Among Kids 3
(Date:7/22/2008)... and pegylated enzyme produces significantly en... - Pegylated enzyme well tolerated ...alozyme Therapeutics,Inc. (Nasdaq: HALO ), a bio...ing products targeting the extracellular matrix, t...inical animal efficacy data,for its pegylated-rHuP...
(Date:7/22/2008)...Approach of LASH (Laser Assisted Scar Healing)... MARSEILLES, France, July 22 /- Ekkyo...dicine company, which develops first-in-class,lase...tion, announced today,the publication of a scienti...orting the results of a pilot study on cutaneous s...
(Date:7/21/2008)... 2008 conferences, GAITHERSBURG, Md., July 21 /PR... company developing gene therapies for HIV and gen...6 Phase I and Phase II,clinical trials for the med...s an investigational gene therapy for the treatmen...rsday, July 24, 2008 at 11 a.m. EDT. The,presentat...
(Date:7/21/2008)...impedance spectroscopy (BIS) is,more accurate and ...ent of,lymphedema in breast cancer patients, accor...Journal of Clinical Oncology (2008; Vol. 26, Issue...t Cancer: Incidence, Risk Factors, and,Effect on U... Hayes, PhD.,and colleagues from Queensland Unive...
Breaking Medicine Technology:Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 2Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 3Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 4Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 5Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Medicine" 2Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Medicine" 3VIRxSYS to Host a Web Conference to Announce Clinical Trial Update 2VIRxSYS to Host a Web Conference to Announce Clinical Trial Update 3VIRxSYS to Host a Web Conference to Announce Clinical Trial Update 4VIRxSYS to Host a Web Conference to Announce Clinical Trial Update 5Bioimpedance Spectroscopy is More Accurate and Reliable Than Other Methods of Subclinical Assessment of Lymphedema in Breast Cancer Patients, According to Paper Published in Journal of Clinical Oncology 2Bioimpedance Spectroscopy is More Accurate and Reliable Than Other Methods of Subclinical Assessment of Lymphedema in Breast Cancer Patients, According to Paper Published in Journal of Clinical Oncology 3Into the wild 3447 1Life but not as we know it 3F 3443 1Life but not as we know it 3F 3443 2X rays often repeated for patients in developing countries 20385 1X rays often repeated for patients in developing countries 20385 2X rays often repeated for patients in developing countries 20385 3Renowned Leader and Educator in Robotic Cardiac Bypass Surgery Leverages Cardicas C Port 28R 29 Flex A 28R 29 Anastomosis System in His Practice and t 20381 1Renowned Leader and Educator in Robotic Cardiac Bypass Surgery Leverages Cardicas C Port 28R 29 Flex A 28R 29 Anastomosis System in His Practice and t 20381 2Renowned Leader and Educator in Robotic Cardiac Bypass Surgery Leverages Cardicas C Port 28R 29 Flex A 28R 29 Anastomosis System in His Practice and t 20381 3Renowned Leader and Educator in Robotic Cardiac Bypass Surgery Leverages Cardicas C Port 28R 29 Flex A 28R 29 Anastomosis System in His Practice and t 20381 4
...YTOWN, N.Y., June 15, 2007 /PRNewswire-FirstCall/ ... of scientific studies that,(1) demonstrate that A...ple types of human tumors in animal models, (2) re...cts, and (3) show that,MPC-6827 is not affected by...drug resistance. The study results appear in the J...
...HIGH WYCOMBE, England, June 18, 2007 /PRNewswire/ ...g how a new flu vaccine has the,potential to prote...demic and annual, was presented today by PepTcell,...VI (Options) Conference, in,Toronto, Canada. , The...the,European Journal of Immunology, showed how mic...
Other Medicine Technology:New Research Demonstrates Broad Efficacy of Azixa (MPC-6827),Against Multiple Tumor Types and in Drug Resistant Cell Lines 2New Research Demonstrates Broad Efficacy of Azixa (MPC-6827),Against Multiple Tumor Types and in Drug Resistant Cell Lines 3New Research Demonstrates Broad Efficacy of Azixa (MPC-6827),Against Multiple Tumor Types and in Drug Resistant Cell Lines 4New Research Demonstrates Broad Efficacy of Azixa (MPC-6827),Against Multiple Tumor Types and in Drug Resistant Cell Lines 5New Research Demonstrates Broad Efficacy of Azixa (MPC-6827),Against Multiple Tumor Types and in Drug Resistant Cell Lines 6New Flu Vaccine From PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 2New Flu Vaccine From PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 3New Flu Vaccine From PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 4
...ll-natural moisturizing mist for the eyes develope...thers, from Oregon Health Sciences University's Ca...TEARS (2000) and dry eye patients showed, on avera...he eyes' tear film without disrupting the tear fil...
Finally, a camera that sees the way you do!,Combined with the MicroLux DVR (Digital Video Recorder), the MicroLux Headlight Camera System gives you an entirely new way to visualize, edit, share and
This latest sensor array with 275 channels gives an average inter-channel spacing of just 2.2 cm. This high-density array is particularly useful when using advanced analysis techniques, such as Synt
...ement position is achieved using an increased tilt...tient bed. The patient preparation can be carried ...ency the patient can be brought rapidly outside th...he integrated neck support increases patient safet...
Medicine Products: